Michael Baker

Michael Baker

Director/Board Member at
Radiopharm Theranostics (USA), Inc.

Net worth: 418 064 $ as of 31/05/2026

Health Technology
Consumer Services
Finance

Profile

Michael Baker is currently Director at Radiopharm Theranostics (USA), Inc. and Investment Associate at Bioscience Managers Pty Ltd. Former roles include Chief Executive Officer, MD & Director at Arovella Therapeutics Ltd. from 2021 to 2026, Independent Non-Executive Director at Radiopharm Theranostics Ltd. from 2021 to 2024, and Senior Manager at Hexima Ltd. Education includes an MBA from Melbourne Business School and undergraduate and graduate degrees from La Trobe University, conferred in 2004 and 2009 respectively.

Known holdings in public companies

CompanyDateNumber of sharesValuationValuation date
04/05/2026 8,184,493 ( 0.68% ) 418 064 $ 31/05/2026

Michael Baker active positions

CompaniesPositionStart
Private Equity Analyst 01/11/2017
Director/Board Member -

Former positions of Michael Baker

CompaniesPositionEnd
AROVELLA THERAPEUTICS LIMITED Chief Executive Officer 04/05/2026
RADIOPHARM THERANOSTICS LIMITED Director/Board Member 26/03/2024
HEXIMA LIMITED Corporate Officer/Principal -
See the detail of Michael Baker's experience

Training of Michael Baker

Experiences
Positions held

Active

Inactive

Listed companies

Private companies

Connections

32

1st degree connections

7

1st degree companies

Male

Female

Members of the board

Executives

Linked companies

Private companies7

Consumer Services

Health Technology

Health Technology

Consumer Services

Finance

Health Services

Health Technology